Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Bristol-Myers Squibb Company (BMS or 'the company') is a global biopharmaceutical company. The company is involved in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of innovative medicines. It develops medicines in various therapeutic areas that primarily include cardiovascular and oncology. BMS markets its products under Baraclude, Sustiva, Reyataz, Plavix, Pomalyst, Sustiva, Reblozyl, Opdivo, Eliquis, Orencia, Sprycel, Yervoy, and Empliciti brand names. The company sells products worldwide to wholesalers, retail pharmacies, hospitals, and government entities. It has business presence across the Americas, Europe, and other regions of the world. The company is headquartered in New York City, New York, the US.Scope
- Detailed information on Bristol-Myers Squibb Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bristol-Myers Squibb Company in the form of a SWOT analysis
- An in-depth view of the business model of Bristol-Myers Squibb Company including a breakdown and examination of key business segments
- Intelligence on Bristol-Myers Squibb Company's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bristol-Myers Squibb Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Bristol-Myers Squibb Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bristol-Myers Squibb Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Bristol-Myers Squibb Company's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Bristol-Myers Squibb Company: Company Overview
- Bristol-Myers Squibb Company: Overview and Key Facts
- Bristol-Myers Squibb Company: Overview
- Bristol-Myers Squibb Company: Key Facts
- Bristol-Myers Squibb Company: Key Employees
- Bristol-Myers Squibb Company: Key Employee Biographies
- Bristol-Myers Squibb Company: Major Products and Services
- Bristol-Myers Squibb Company: Management Statement
- Bristol-Myers Squibb Company: Locations and Subsidiaries
- Bristol-Myers Squibb Company: Key Competitors
- Bristol-Myers Squibb Company: Company Analysis
- Bristol-Myers Squibb Company: Business Description
- Bristol-Myers Squibb Company: SWOT Analysis
- Bristol-Myers Squibb Company: SWOT Overview
- Bristol-Myers Squibb Company: Strengths
- Bristol-Myers Squibb Company: Weaknesses
- Bristol-Myers Squibb Company: Opportunities
- Bristol-Myers Squibb Company: Threats
- Bristol-Myers Squibb Company: Corporate Financial Deals Activity
- Bristol-Myers Squibb Company: Financial Deals Overview
- Bristol-Myers Squibb Company: Targets and Partners
- Bristol-Myers Squibb Company: Top Deals 2019 - 2023YTD*
- Bristol-Myers Squibb Company: Advisors
- Bristol-Myers Squibb Company: Top Legal Advisors
- Bristol-Myers Squibb Company: Top Financial Advisors
- Bristol-Myers Squibb Company: Mergers and Acquisitions
- Bristol-Myers Squibb Company: Corporate Venturing
- Bristol-Myers Squibb Company: Capital Raising
- Bristol-Myers Squibb Company: Partnership
- Bristol-Myers Squibb Company: Divestments
- Bristol-Myers Squibb Company: Recent Developments
- Bristol-Myers Squibb Company: News and Events Summary
- Bristol-Myers Squibb Company: Business Expansion
- Bristol-Myers Squibb Company: Financial Deals
- Bristol-Myers Squibb Company: Market Developments
- Bristol-Myers Squibb Company: Red Flags/Distress Signals
- Bristol-Myers Squibb Company: Research & Development
- Bristol-Myers Squibb Company: Strategy and Operations
- Appendix
- Contact Us
- Methodology
Table 1: Bristol-Myers Squibb Company: Key Facts
Table 2: Bristol-Myers Squibb Company: Key Employees
Table 3: Bristol-Myers Squibb Company: Locations and Subsidiaries
Table 4: Bristol-Myers Squibb Company: Key Competitors
Table 5: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Table 7: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Table 9: Bristol-Myers Squibb Company: Targets and Partners
Table 10: Bristol-Myers Squibb Company: Top Deals 2019 - 2023YTD*
Table 11: Bristol-Myers Squibb Company: Legal Advisor Ranking by Value (US$m)
Table 12: Bristol-Myers Squibb Company: Financial Advisor Ranking by Value (US$m)
Table 13: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Bristol-Myers Squibb Company: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Bristol-Myers Squibb Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Bristol-Myers Squibb Company: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Bristol-Myers Squibb Company: Divestments by Geography (2019 - YTD*2023)
Table 23: Bristol-Myers Squibb Company: News and Events Summary
Table 24: Bristol-Myers Squibb Company: Business Expansion
Table 25: Bristol-Myers Squibb Company: Financial Deals
Table 26: Bristol-Myers Squibb Company: Market Developments
Table 27: Bristol-Myers Squibb Company: Red Flags/Distress Signals
Table 28: Bristol-Myers Squibb Company: Research & Development
Table 29: Bristol-Myers Squibb Company: Strategy and Operations
List of Figures
Figure 1: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bristol-Myers Squibb Company: M&A Activity by Geography (TTM*)
Figure 3: Bristol-Myers Squibb Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Bristol-Myers Squibb Company: M&A Average Deal Size - Value (US$m)
Figure 5: Bristol-Myers Squibb Company: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Bristol-Myers Squibb Company: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Bristol-Myers Squibb Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Bristol-Myers Squibb Company: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Bristol-Myers Squibb Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Bristol-Myers Squibb Company: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Bristol-Myers Squibb Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Bristol-Myers Squibb Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Bristol-Myers Squibb Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Bristol-Myers Squibb Company: Divestments by Geography (2019 - YTD*2023)
